$2.1B Endocyte Deal a Record-Breaker

Posted: Updated:
(Image courtesy of Endocyte) (Image courtesy of Endocyte)
WEST LAFAYETTE -

A veteran of Indiana's life sciences industry says the proposed blockbuster sale of West Lafayette-based Endocyte Inc. (Nasdaq: ECYT) is good for the ecosystem in the state. Switzerland-based Novartis AG has signed an agreement to acquire Endocyte for $2.1 billion, which BioCrossroads Project Director Brian Stemme says is "by far" the largest-ever acquisition of an Indiana life sciences company. The deal still faces regulatory and shareholder hurdles.

In an interview with Inside INdiana Business, Stemme said the deal is validation of more than 20 years of support and determination. The company was born in the mid-1990s from biotechnology developed at Purdue University by eventual founder Philip Low and fellow biochemist Christopher Leamon. Low serves as chief science officer and Leamon is vice president of research and development.

"There's been just a lot of people between Dr. Low, Purdue University, the state of Indiana, all the executives and scientists that have been supporting that company over the years, so to see it really be recognized and work with a company that can help get that product to market, it's exciting," Stemme said. "It's a validation that all those folks knew what they were doing, knew what they were talking about, they saw the promise of that technology early and then just kept on grinding."

Stemme says the deal adds to some $8 billion in transactions involving Hoosier life sciences businesses in the last five years, including:

Endocyte is based at Purdue Research Park in West Lafayette, and last month, it was recognized as the first Purdue startup to be valued at $1.5 billion. Purdue President Mitch Daniels says "the sale of Endocyte is a landmark moment, but given the explosion in entrepreneurship and new start-ups at Purdue, I'm sure it's the first of many to come. "We are so deeply proud of our Purdue scientists whose genius is saving lives from cancer, and now has brought great new wealth to Indiana."

Last year, the company acquired a promising prostate cancer therapy in the late stages of development from ABX GmbH in Germany. Endocyte says it expects the acquisition will boost the chances of PSMA-617 going to market. Endocyte went public in 2011, raising $79 million during its initial public offering.

BioCrossroads Project Director Brian Stemme said the deal is validation of more than 20 years of support and determination.
  • Perspectives

    • What Makes Up Quality of Place?

      Economic development is a hot topic these days. With the economy continuing to chug along in robust fashion and unemployment approaching historic lows, communities are refining their objectives and priorities to eek every drop of benefit they can from these financially strong times. Nowhere is this focus greater than with “quality of place,” As cities and states think about how they can distinguish themselves from their peers, a common starting point is developing a...

    More

Subscribe

Name:
Company Name:
Email:
Confirm Email:
HTML
INside Edge
Morning Briefing
BigWigs & New Gigs
Life Sciences Indiana
Indiana Connections
INPower
Subscribe
Unsubscribe

Events



  • Most Popular Stories

    • Computer Science, Gaming Collide With 'Hour of Code'

      Elementary school students in the Metropolitan School District of Decatur Township in Indianapolis are getting an early lesson in coding through the international Hour of Code program. The initiative is designed to give people an introduction to computer science and coding, and Lynn Hodgkin, elementary media coordinator for the district, says it takes a game-centered approach to teaching coding to kids. The students are participating in the Hour of Code at the...

    • St. Vincent Names Manas Regional President

      Julie Manas has been selected to serve as regional president of the St. Vincent North Region, which includes St. Vincent Anderson, Carmel, Fishers, Kokomo, Mercy, Randolph and Williamsport hospitals. She has more than 30 years of healthcare experience and most recently comes from Hospital Sisters Health System, Western Wisconsin Division, where she held the role of president and chief executive officer.

    • The Heritage Group Founder to be Remembered

      Services are set for noted businessman and philanthropist Fred Fehsenfeld, founder of Indianapolis-based The Heritage Group, who passed away last week at the age of 94. Fehsenfeld, a graduate of Purdue University and decorated World War II veteran, will be remembered Saturday during a Celebration of Life, at The Center on the northwest side of Indianapolis.

    • On-Air

      Find out when and where you can watch and listen to our reports.

    • Holcomb Details 2019 Next Level Agenda

      Governor Eric Holcomb has unveiled his legislative and administrative priorities ahead of the 2019 Indiana General Assembly. The governor says his Next Level Agenda continues an ongoing focus on jobs, economic growth, health, infrastructure and government service. During a presentation Thursday, the governor also revealed his Next Level Trails program, which aims to provide $90 million in grants for new hiking, biking and riding trails throughout the state.